Jump to Navigation

Suboxone: A Primer

Suboxone (buprenorphine/naloxone) was approved by the FDA on October 8, 2002 for the treatment of opioid addiction. Until the approval of Suboxone, we had two options for treating opioid addiction— naltrexone and methadone.

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.